Digest Network Come funziona
Network
/
Società
Sa
Non verificato

Sarepta Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIgiene alimentareSaluteScienza

76 comunicati stampa

Guarda tutti i comunicati
22/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Igiene alimentare
Biotecnologia
Scienza
Farmaceutica
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
31/03/2026
Mercato azionario
Igiene alimentare
Salute
Scienza
Farmaceutica
Biotecnologia
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/03/2026
Web e Social Network
Telefonia e Varie
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/03/2026
Web e Social Network
Telefonia e Varie
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
19/03/2026
Industria
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
16/03/2026
Salute
Igiene alimentare
Biotecnologia
Scienza
Farmaceutica
Industria
Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/02/2026
Appalti e gare
Università
Biotecnologia
Scuola/Istruzione
Igiene alimentare
Salute
Farmaceutica
Politica Locale
Scienza
Vetrine/Shopping
Sarepta Therapeutics Announces Call for Applications for the 9th Annual Route 79, The Duchenne Scholarship Program
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
26/02/2026
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Cardiologia
Sanità
Farmaceutica
Salute
Sarepta Therapeutics to Present New Long-Term and Safety Data Across Gene Therapy and Exon-Skipping Programs at 2026 Muscular Dystrophy Association Clinical & Scientific Congress
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/02/2026
Industria
Scienza
Cardiologia
Biotecnologia
Salute
Igiene alimentare
Medicina - Varie
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0